Michael Englesbe, MD

Visiting Professor, Surgery-Transplant

Provider Credentials
Doctor of Medicine
Faculty Photo
Undergraduate School
  • BA, Yale University (CT) (1993)
  • MD, Rutgers University–New Brunswick (NJ) (1997)
Residency
  • University of Michigan Hospitals and Health Centers Program, Chief Resident, Surgery (2004)
Fellowships
  • University of Michigan Hospitals and Health Centers Program, Transplant Surgery (2006)
Department
Surgery-Transplant

Professional Titles

  • Chair of Surgery
  • Aragón/Gonzalez-Gíustí Chair
  • Professor of Surgery

Practice Locations

UCHealth Transplant Surgery - Anschutz Medical Campus
1635 Aurora Ct
7th Floor
Aurora, CO 80045
720-848-0833

Specialty Information

Specialties
  • Surgery
Care Philosophy
Michael Englesbe, MD, is the Aragón/Gonzalez-Gíustí Chair of the Department of Surgery at the University of Colorado Anschutz. Englesbe is one of the nation’s leading transplant surgeons and an authority on building effective clinical programs, improving hospital quality and safety, and leading training environments. Englesbe earned his undergraduate degree in biology at Yale University and medical degree at the Robert Wood Johnson Medical School in New Jersey. He completed residency in general surgery at the University of Michigan Health System, a surgical research fellowship at the University of Washington Medical School, and a fellowship in multi-organ transplantation at University of Michigan Health System. Prior to joining CU Anschutz Surgery, he was a member of the University of Michigan faculty for over 20 years. At the University of Michigan, Englesbe served as the Cyrenus G. Darling Sr. & Cyrenus G. Darling Jr. Professor of Surgery and section head and chief of transplant surgery. As transplant chief, he directed the statewide Collaborative Quality Initiative portfolio while leading multiple federally funded research initiatives all focused on making care better, safer, and more effective across the state of Michigan. Englesbe is principal investigator or mentor on more than $140 million in sponsored research grants and contracts. His scholarship includes more than 390 peer-reviewed publications, multiple authored books, and articles in influential policy outlets, including Harvard Business Review and NEJM Catalyst.